3 unknown. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Zhao Weili: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma CAR-T Therapy - Peripheral T Cell Lymphoma | Early Phase 1 | Unknown | Zhao Weili | 35 | 2023-09-01 | 2023-08-21 |
| A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL Tafasitamab Injection - Diffuse Large B-cell Lymphoma | Unknown | Zhao Weili | 15 | 2023-07-01 | 2023-06-01 | |
| Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma JWCAR029 - Non Hodgkin Lymphoma | Phase 1 | Unknown | Zhao Weili | 10 | 2018-01-05 | 2019-07-12 |
Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Peripheral (1)
Immunotherapy, Adoptive (1) · Lenalidomide (1) · relmacabtagene autoleucel (1) · tafasitamab (1)
China (3)